Global Topical Contraceptive Market to Grow at a CAGR of 2%, 2017-2021 with Allergan, Mylan, Merck Millipore, Pfizer & Teva Pharmaceuticals Dominating - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Topical Contraceptive Market 2017-2021" report to their offering.

The global topical contraceptive market to grow at a CAGR of 2% during the period 2017-2021.

The report, Global Topical Contraceptive Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is increasing demand for other contraceptive methods. Other contraceptive methods are becoming more popular among women than topical contraceptives. This is because of the increased advantages provided by them. For instance, the demand for IUD, sterilization, female condoms, and oral pills is increasing.

According to the report, one driver in the market is proliferation of strategic initiatives. Innovation and effectiveness of female contraceptives are the key to market growth. Several vendors are entering into strategic alliances and investing in R&D for product innovation and better financial stability, thereby developing the latest products with better efficiency, safety, and protection.

Key vendors

  • Allergan
  • Mylan
  • Merck Millipore
  • Pfizer
  • Teva Pharmaceuticals

Other prominent vendors

  • Afaxys
  • Agile Therapeutics
  • Ansell
  • Bayer Pharma
  • Caya
  • Ferring Pharmaceuticals
  • Female Health
  • Fuji Latex
  • HLL Lifecare
  • Janssen Pharmaceutical
  • Lipocine
  • Lupin Pharmaceuticals
  • Mayer Laboratories
  • Okamoto Industries
  • Reckitt Benckiser
  • Syzygy Healthcare

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Market landscape

PART 05: Geographical segmentation

PART 06: Distribution channel segmentation

PART 07: Decision framework

PART 08: Drivers and challenges

PART 09: Market trends

PART 10: Vendor landscape

For more information about this report visit http://www.researchandmarkets.com/research/btln52/global_topical

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health